Costa Rican Natural History Study of HPV and Cervical Neoplasia

NCT00342173 | Terminated

• 2 other identifiers: 999999030OH99-C-N030
• Study Type: observational
• Target: 11,545
• Locations: 1 country
• Sites: 1

Brief Summary

A population-based study was initiated in Costa Rica in June 1993 to investigate the natural history of human papillomaviruses (HPV) and cervical neoplasia. Over a period of 18 months, ending in December 1994, 10,080 women were recruited into our study, after informed consent was obtained. At the initial recruitment visit, all women were administered a brief risk factor questionnaire, had 15ml of blood collected and, if sexually active, were given a pelvic examination. At the time of the pelvic examination, a Pap smear was collected, as were additional cervical cells which were then used for additional monolayer smears (ThinPrep) and for human papillomavirus and other testing. Pictures of the cervix, known as cervigrams, were also taken as a third screening test. Based on these screening tests, women were referred to colposcopy, at which time a more detailed risk factor questionnaire was administered, additional cervical cells and blood (15ml) were collected, and histological specimens were obtained, if indicated by the colposcopy. Women diagnosed with a high-grade cervical lesion (HSIL) or cervical cancer were treated by Social Security Administration clinicians using standard local protocols. Women without evidence of HSIL or cancer at enrollment comprise the group of subjects who have been followed as part of our longitudinal study. Three distinct groups of women of approximately equal size (about 3,000 women each) exist within our longitudinal cohort. The first group consists of women who at enrollment had evidence of low-grade cervical lesions (LSIL) or equivocal lesions and a sample of the remaining cohort members. This group is being followed actively at 6-12 month intervals through their seventh anniversary in the cohort. The second group consists of women who were cytologically normal at enrollment but randomly selected for active follow-up. This second group will be seen once after enrollment, at their fifth anniversary in the cohort. Women in this group with evidence of LSIL at the fifth anniversary visit will be added to the first group described above and followed at 6-month intervals. The final group consists of the remaining women in our cohort (all cytologically normal at enrollment). These women are being followed passively via linkage to the cytology and tumor registries in Cost Rica. Clinical visits conducted during follow-up consist of a brief personal interview that collects information on exposures since enrollment, the collection of 15ml blood, and a pelvic examination. Pap smear is prepared during the pelvic examination, and additional cervical specimens are collected and used to prepare a monolayer smear (ThinPrep) and for human papillomavirus and other testing. Similar to the enrollment visit, cervigrams are also collected from each participant at the time of their follow-up visits. During follow-up, women with any evidence of progression to HSIL or cancer (by Pap smear, ThinPrep, cervicography, or by visual inspection) are referred to colposcopy, censored from the study, and treated by Social Security Administration clinicians using standard local protocols.

Conditions

Cervical Neoplasia

Keywords

Cervix; Natural History; Neoplasia; HPV; Costa Rica

Outcome Measures

Primary Outcomes (1)

• Natural History of human papillomaviruses (HPV) and cervical neoplasia

  Cervical precancer and cancer

  7-year follow-up

Study Arms (1)

Women in Costa Rica

Examining the natural history of HPV and cervical neoplasia in Costa Rican women.

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

A population-based study was initiated in Costa Rica in June 1993 to investigate the natural history of human papillomaviruses (HPV) and cervical neoplasia. Over a period of 18 months, ending in December 1994, 10,080 women were recruited into our study, after informed consent was obtained. Three distinct groups of women of approximately equal size (about 3,000 women each) exist within our longitudinal cohort. The first group consists of women who at enrollment had evidence of low-grade cervical lesions (LSIL) or equivocal lesions and a sample of the remaining cohort members. The second group consists of women who were cytologically normal at enrollment but randomly selected for active follow-up. The final group consists of the remaining women in our cohort (all cytologyically normal at enrollment).

You may qualify if:

• Less than 35 years of age.
• Intact uterus (non-hysterectomized).
• In good general health.
• Non-pregnant.
• For women not using OCs: Having regular cycles \[cycles 25-35 days in length\].
• HPV16 seropositive \[based on data from latest visit tested\].
• No evidence of HSIL/cancer \[based on data from latest visit within cohort\].
• Willing to participate \[informed consent\].
• Must be between the ages of 45 to 70 years.
• Women who do not have a final diagnosis of HSIL.

Sponsors & Collaborators

• National Cancer Institute (NCI): lead

Study Sites (1)

Costa Rican Social Security Administration

Tres Ríos, Costa Rica

Location

Related Publications (1)

• Campos NG, Burger EA, Sy S, Sharma M, Schiffman M, Rodriguez AC, Hildesheim A, Herrero R, Kim JJ. An updated natural history model of cervical cancer: derivation of model parameters. Am J Epidemiol. 2014 Sep 1;180(5):545-55. doi: 10.1093/aje/kwu159. Epub 2014 Jul 31.

  PMID: 25081182 BACKGROUND

MeSH Terms

Conditions

Neoplasms

Study Officials

• Mark H Schiffman, M.D.

  National Cancer Institute (NCI)

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: NIH
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: June 19, 2006
• First Posted: June 21, 2006
• Study Start: May 20, 1999
• Primary Completion: March 12, 2012
• Study Completion: March 12, 2012
• Last Updated: March 16, 2020

Record last verified: 2020-03

Locations

CO (1)